Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07802730 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase 1 PK Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients

Name: Phase 1 PK Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients — clinical trial record (NCT07802730)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorAeroRx Therapeutics Inc.

Started2026-09

View on ClinicalTrials.gov ↗

This is a phase 1, single-dose, 2-period crossover study in healthy volunteers to compare the systemic pharmacokinetic (PK) profile of inhaled AERO-002 versus inhaled active comparator product.

Trial Details

NCT Number	NCT07802730
Lead Sponsor	AeroRx Therapeutics Inc. Collaborators: Medicines Evaluation Unit Ltd
Conditions	COPD (Chronic Obstructive Pulmonary Disease)
Enrollment	24 participants
Start Date	2026-09
Primary Completion	2026-12 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-09-03